Literature DB >> 28665476

Incidence and Evolution of Subretinal Precipitates in Optic Disc Pit Maculopathy.

Irini Chatziralli1, George Theodossiadis1, Dimitrios Brouzas2, Panagiotis Theodossiadis1.   

Abstract

PURPOSE: To study the evolution of subretinal precipitates coexistent with optic disc pit (ODP) maculopathy from their appearance at baseline examination until their absorption after successful treatment.
METHODS: Participants in this retrospective, multicenter study were 42 patients with ODP maculopathy, in whom complete ocular examination was performed, including visual acuity (VA) measurement, slit-lamp examination, color or red-free fundus photography, and optical coherence tomography at baseline after surgical treatment.
RESULTS: Out of 42 cases, 17 (40.5%) cases of ODP maculopathy, which were examined between 2002 and 2015, were found to have subretinal precipitates associated with multilayer fluid accumulation at baseline. Precipitates were located at the outer part of the photoreceptor layer and remained for 3-6 months after successful treatment and absorption of subretinal fluid. The mean VA was 0.99 ± 0.21 logMAR at baseline and improved to 0.54 ± 0.25 logMAR at the final examination.
CONCLUSIONS: Macular precipitates in association with signs of disease chronicity, such as multilayer fluid accumulation, became evident at baseline examination. Precipitates' disappearance in 15 out of 17 cases coincided with the absorption of subretinal fluid. The relative low VA at baseline probably could be attributed to the chronicity of the disease.

Entities:  

Keywords:  Maculopathy; Optic disc pit; Optical coherence tomography; Precipitates

Mesh:

Year:  2017        PMID: 28665476     DOI: 10.5301/ejo.5000999

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  1 in total

1.  A Case of Multiple Optic Disc Pits: 21-Year Follow-up

Authors:  Osman Melih Ceylan; Alper Can Yılmaz; Ali Hakan Durukan; Mehmet Talay Köylü; Fatih Mehmet Mutlu
Journal:  Turk J Ophthalmol       Date:  2021-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.